• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.07% Nasdaq Up0.56%

    ImmuCell Corp. (ICCC)

    -NasdaqCM
    6.05 0.00(0.00%) Apr 20
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 2,205   1,770   1,540   2,082  
    Cost of Revenue863  692  661  932  
    Gross Profit 1,343   1,078   879   1,150  
    Operating Expenses
    Research Development463  361  761  594  
    Selling General and Administrative681  676  577  543  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 199   41   (459) 13  
    Income from Continuing Operations
    Total Other Income/Expenses Net(10)(11)(16)(11)
    Earnings Before Interest And Taxes188  30  (475)1  
    Interest Expense -   -   -   -  
    Income Before Tax188  30  (475)1  
    Income Tax Expense58  19  (180)14  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops131  10  (295)(13)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 131   10   (295) (13)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 131   10   (295) (13)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.